Screening for Colorectal Cancer: The Business Case

Robert H. Fletcher, MD, MSc;Graham A. Colditz, MD, DrPH;L. Greg Pawlson, MD;Howard Richman, JD;David Rosenthal, MD;Patricia R. Salber, MD, MBA;

Publication

Article

June 1, 2002

The American Journal of Managed Care

June 2002

Volume8

Issue 6

Screening for Colorectal Cancer: The Business Case

Author(s):

Robert H. Fletcher, MD, MSc,Graham A. Colditz, MD, DrPH

Download PDF: Screening for Colorectal Cancer: The Business Case

Articles in this issue

Robbing Tomorrow's Generations

Consumer Response to a Report Card Comparing Healthcare Systems

Screening for Colorectal Cancer: The Business Case

A Nurse-Based Pilot Program to Reduce Cardiovascular Risk Factors in a Primary Care Setting

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

"My Patients Are Sicker:" Using the Pra Risk Survey for Case Finding and Examining Primary Care Site Utilization Patterns in a Medicare-Risk MCO

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Screening for Colorectal Cancer: The Business Case

Newsletter